Based on the information provided, I found one source that discusses clinical decision support tools related to antibiotic dosing, including tigecycline. However, it does not explicitly mention if a specific tool covers tigecycline dosing. Nonetheless, I am providing the information I found to be most relevant.

Clinical decision support tools are designed to assist healthcare professionals in making appropriate treatment decisions for patients. These tools can provide evidence-based recommendations and alerts for various medical interventions, including antibiotic dosing [1].

Tigecycline is an antibiotic used to treat various bacterial infections. Its dosing regimen depends on the patient's renal function and the type of infection being treated [2].

According to DrugPatentWatch.com, tigecycline is available under the brand name Tygacil, which is marketed by Pfizer [3]. However, DrugPatentWatch.com does not provide information on clinical decision support tools specifically covering tigecycline dosing.

In summary, while clinical decision support tools can provide guidance on antibiotic dosing, I could not find specific information on tools that cover tigecycline dosing. Healthcare professionals should consult trusted medical resources and guidelines when determining appropriate tigecycline dosing for their patients.

Sources:
[1] Clinical Decision Support. (n.d.). In National Center for Biotechnology Information. Retrieved March 24, 2023, from https://www.ncbi.nlm.nih.gov/books/NBK98153/
[2] Tigecycline: MedlinePlus Drug Information. (2021, December 10). In MedlinePlus. Retrieved March 24, 2023, from https://medlineplus.gov/druginfo/meds/a607045.html
[3] Tigecycline (Tygacil) Patent Expiration & Generics. (n.d.). In DrugPatentWatch. Retrieved March 24, 2023, from https://www.drugpatentwatch.com/patent/tigecycline-tygacil-pfizer-inc/